FGF21 mutants and uses thereof

Details for Australian Patent Application No. 2009302318 (hide)

Owner Amgen Inc.

Inventors Walker, Kenneth W.; Gegg Jr., Colin V.; Hecht, Randy I.; Belouski, Edward J.; Li, Yue-Sheng; Michaels, Mark L.; Xu, Jing; Ellison, Murielle M.

Agent Shelston IP

Pub. Number AU-A-2009302318

PCT Pub. Number WO2010/042747

Priority 61/195,761 10.10.08 US

Filing date 8 October 2009

Wipo publication date 15 April 2010

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/042747 Priority application(s): WO2010/042747

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009302325-Method and compositions for producing fatty aldehydes

2009302317-Iterative multi-scale method for flow in porous media